← Eichor
Condition: Venentoclax Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Venentoclax

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Maintenance Treatment of "ITIVA" in AML Patients
NA · 1 location(s) · Henan Cancer Hospital · NCT06256627Venetoclax Combined With Azacitidine for Consolidation Therapy in AML
Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07425782Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic He
Phase 3 · 18 location(s) · First Affiliated Hospital of Zhejiang University · NCT07396480
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.